Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer.

被引：2
|
作者：
Gajria, D. [1 ]
King, T. A. [1 ]
Pannu, H. [1 ]
Sakr, R. [1 ]
Seidman, A. D. [1 ]
Syldor, A. [1 ]
Patil, S. [1 ]
Maybody, M. [1 ]
Norton, L. [1 ]
Rosen, N. [1 ]
Hudis, C. [1 ]
Chandarlapaty, S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
574
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer
    Canonici, Alexandra
    Gijsen, Merel
    Mullooly, Maeve
    Bennett, Ruth
    Bouguern, Noujoude
    Pedersen, Kasper
    O'Brien, Neil A.
    Roxanis, Ioannis
    Li, Ji-Liang
    Bridge, Esther
    Finn, Richard
    Slamon, Dennis
    McGowan, Patricia
    Duffy, Michael J.
    O'Donovan, Norma
    Crown, John
    Kong, Anthony
    ONCOTARGET, 2013, 4 (10) : 1592 - 1605
  • [12] HER2 overexpressing metastatic breast cancer.
    Spigel D.R.
    Burstein H.J.
    Current Treatment Options in Oncology, 2002, 3 (2) : 163 - 174
  • [13] mTORC1 Activity Contributes to the Mcl-1 Dependence of HER2 Amplified Breast Cancer Cells
    Campone, M.
    Noel, B.
    Gouraud, W.
    Jezequel, P.
    Barille-Nion, S.
    Juin, P.
    CANCER RESEARCH, 2009, 69 (24) : 644S - 644S
  • [14] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Avisek Majumder
    Manbir Sandhu
    Debarko Banerji
    Veronica Steri
    Adam Olshen
    Mark M. Moasser
    Scientific Reports, 11
  • [15] Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases.
    Kodack, D. P.
    Chung, E.
    Yamashita, H.
    Incio, J.
    Peters, A.
    Song, Y.
    Ager, E.
    Huang, Y.
    Farrar, C.
    Lussiez, A.
    Goel, S.
    Snuderl, M.
    Kamoun, W.
    Hiddingh, L.
    Tannous, B. A.
    Fukumura, D.
    Engelman, J. A.
    Jain, R. K.
    CANCER RESEARCH, 2012, 72
  • [16] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Majumder, Avisek
    Sandhu, Manbir
    Banerji, Debarko
    Steri, Veronica
    Olshen, Adam
    Moasser, Mark M.
    SCIENTIFIC REPORTS, 2021, 11 (01) : 9091
  • [17] Phase I study of LJM716, BYL719, and trastuzumab in patients (pts) with HER2-amplified (HER2+) metastatic breast cancer (MBC).
    Shah, Payal Deepak
    Chandarlapaty, Sarat
    Dickler, Maura N.
    Ulaner, Gary
    Zamora, Stephen James
    Sterlin, Valentina
    Iasonos, Alexia
    Coughlin, Christina Marie
    Morozov, Alex
    Ero, Joy
    Rosen, Neal
    Gilewski, Teresa
    Fornier, Monica Nancy
    Sklarin, Nancy T.
    Berger, Michael F.
    Moynahan, Mary Ellen
    Hudis, Clifford A.
    Baselga, Jose
    Modi, Shanu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [18] A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer
    Taiki Hashimoto
    Daisuke Takayanagi
    Junpei Yonemaru
    Tomoaki Naka
    Kengo Nagashima
    Erika Machida
    Takashi Kohno
    Yasushi Yatabe
    Yukihide Kanemitsu
    Ryuji Hamamoto
    Atsuo Takashima
    Kouya Shiraishi
    Shigeki Sekine
    British Journal of Cancer, 2023, 129 : 1176 - 1183
  • [19] A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer
    Hashimoto, Taiki
    Takayanagi, Daisuke
    Yonemaru, Junpei
    Naka, Tomoaki
    Nagashima, Kengo
    Machida, Erika
    Kohno, Takashi
    Yatabe, Yasushi
    Kanemitsu, Yukihide
    Hamamoto, Ryuji
    Takashima, Atsuo
    Shiraishi, Kouya
    Sekine, Shigeki
    BRITISH JOURNAL OF CANCER, 2023, 129 (07) : 1176 - 1183
  • [20] Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
    Ma, Cynthia X.
    Bose, Ron
    Gao, Feng
    Freedman, Rachel A.
    Telli, Melinda L.
    Kimmick, Gretchen
    Winer, Eric
    Naughton, Michael
    Goetz, Matthew P.
    Russell, Christy
    Tripathy, Debu
    Cobleigh, Melody
    Forero, Andres
    Pluard, Timothy J.
    Anders, Carey
    Niravath, Polly Ann
    Thomas, Shana
    Anderson, Jill
    Bumb, Caroline
    Banks, Kimberly C.
    Lanman, Richard B.
    Bryce, Richard
    Lalani, Alshad S.
    Pfeifer, John
    Hayes, Daniel F.
    Pegram, Mark
    Blackwell, Kimberly
    Bedard, Philippe L.
    Al-Kateb, Hussam
    Ellis, Matthew J. C.
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5687 - 5695
12345